CMS Rolls Back Harmful Proposals in Medicare Part D

Monday, May 20, 2019


Weekly Policy Update: CMS Proposed Rule is a Step Forward for the Coverage of Breakthrough Technologies

Monday, May 13, 2019

In late April, the Centers for Medicare and Medicaid Services (CMS) publicly released its FY 2020 Inpatient Prospective Payment System (IPPS) Proposed Rule. The rule is a critical step forward for coverage and payment of medical devices, and makes it more likely that breakthrough products will be covered and adequately paid for by CMS.  

Weekly Policy Update: The Final Tally - 2019 Legislative Session Comes to a Close

Friday, May 03, 2019

CBSA has worked hard this session to advocate on behalf of the industry. We’ve worked with our members and partners to advance proposals that promote patient safety, protect patient access, and enhance workforce development efforts, while coordinating to convey concerns with problematic legislation and mitigate threats to the industry in Colorado. 

Weekly Policy Update: One Week Left - What Will Make It Across the Finish Line

Friday, April 26, 2019


CBSA Opposes Drug Importation and Continues to Advocate for Safe Policy to Reduce Patient Costs

Monday, April 22, 2019

Last week CBSA testified in the House Health and Insurance Committee in opposition to Senate Bill 005 - Import Prescription Drugs From Canada, which would require the Department of Health Care Policy and Financing to design a program to import prescription drugs from Canada for sale to Colorado consumers. CBSA expressed our concerns that opening up the U.S. supply chain would jeopardize safety by exposing patients to counterfeit, adulterated or unapproved drugs and would result in minimal savings for consumers. In fact, both the Department of Health and Human Services and the Congressional Budget Office have stated that savings from importation would be minimal; estimates suggest less than one percent.  

Weekly Policy Update: CBSA Applauds Introduction of House Bill to Permanently Repeal Medical Device Excise Tax

Friday, April 12, 2019

This week bipartisan legislation was introduced in the U.S. House of Representatives to permanently repeal the medical device excise tax. CBSA applauds the introduction of H.R. 2207, Protect Medical Innovation Act of 2019, which gets us one step closer to providing innovators the long-term certainty they need to support future job growth and sustainable, cutting-edge research and development.  

Weekly Policy Update: Drug Pricing Transparency Bill Introduced in Colorado, Plus CBSA Advocates in DC

Friday, April 05, 2019


Weekly Policy Update: CBSA Raises Concerns about Importing Drugs From Canada, Plus A Full Review of this Month In Policy

Friday, March 29, 2019

This week President & CEO Jennifer Jones Paton spoke with 630 KHOW’s Krista Kafer about CBSA’s opposition to Senate Bill 5, which would create a Canadian drug importation program in Colorado. Throughout the conversation Jennifer explained that the innovators CBSA represents are dedicated to developing new treatments and cures and ensuring patients have access to those medicines, but this legislation would jeopardize patient safety and do little to reduce prescription drug costs.  

Weekly Policy Update: Colorado State Budget and Forecast, Plus CBSA Voices Concerns on Drug Pricing Legislation

Friday, March 22, 2019


Weekly Policy Update: Family Medical Leave Insurance Program and the President's Proposed Budget

Friday, March 15, 2019

On Wednesday Senate Bill 188, FAMLI Family Medical Leave Insurance Program, was heard and passed out of the Senate Committee on Business, Labor & Technology. The bill would create a state-run family and medical leave insurance program to provide partial wage replacement benefits to an eligible individual who takes leave from work: